Dexmedetomidine and Fentanyl are compared being an adjuvant to Levobupivacaine in case of upper limb surgeries

Comparison of dexmedetomidine & fentanyl as an adjuvant to levobupivacaine in peripheral nerve stimulator guided supraclavicular brachial plexus block - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069905

Enrollment

104

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Fentanyl: Fentanyl as an adjuvant to levobupivacaine in case of elective upper limb surgeries under Supraclavicular Brachial Plexus Block Control Intervention1: Dexmedetomidine: Dexmede

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 and 2 All patients scheduled for elective upper limb surgeries under Supraclavicular Brachial Plexus Block

Exclusion criteria

Exclusion criteria: Patient not giving consent Age less than 18 years and more than 60years ASA grade 3 and more Patients with abnormal coagulation profile Patient with history of opioid abuse Patients with local skin site infections Patients with hypersensitivity to any of the drugs used Pregnant and lactating mothers Failure of Block

Design outcomes

Secondary

Measure	Time frame
Onset of sensory & motor blockadeTimepoint: For approximately 60 minutes after the administration of the drug	—

Primary

Measure	Time frame
Duration of sensory and motor blockade in the form of response to pin prick test and modified bromage scaleTimepoint: 300 minutes or the entire duration of surgery whichever is earlier	—

Countries

India

Contacts

Public ContactDr Mahima Batra

Peoples College of Medical Sciences

drmahimabatra@gmail.com9752075418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026